[Header],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Investigator Name,mq1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Project Name,Illumina Controls UK10K_NEURO_UKSCZ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Experiment Name,6946,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Date,2011-10-14T16:32:00,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Workflow,LibraryQC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Chemistry,Default,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
[Reads],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
[Settings],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
[Manifests],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
[Data],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lane,Sample_ID,Sample_Name,GenomeFolder,Index,alignments_in_bam,bait_name,default_library_type,default_tag_sequence,email_addresses,email_addresses_of_followers,email_addresses_of_managers,email_addresses_of_owners,is_control,is_pool,lane_id,lane_priority,library_name,organism,organism_taxon_id,project_cost_code,project_id,project_name,qc_state,request_id,required_insert_size_range,sample_accession_number,sample_common_name,sample_consent_withdrawn,sample_description,sample_id,sample_name,sample_public_name,sample_reference_genome,separate_y_chromosome_data,spiked_phix_tag_index,study_accession_number,study_contains_nonconsented_human,study_contains_nonconsented_xahuman,study_description,study_id,study_name,study_reference_genome,study_title,tag_index,
1,4488737,EGAN00001017479,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017479,Homo sapiens,,,1092801,UK10K_UKSCZ5072921,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
1,4488725,EGAN00001017480,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017480,Homo sapiens,,,1092803,UK10K_UKSCZ5072922,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
1,4488713,EGAN00001017481,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017481,Homo sapiens,,,1092805,UK10K_UKSCZ5072923,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
1,4488701,EGAN00001017482,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017482,Homo sapiens,,,1092807,UK10K_UKSCZ5072924,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
1,4488689,EGAN00001017483,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017483,Homo sapiens,,,1092809,UK10K_UKSCZ5072925,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
1,4488677,EGAN00001017484,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017484,Homo sapiens,,,1092811,UK10K_UKSCZ5072926,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
1,4488665,EGAN00001017485,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017485,Homo sapiens,,,1092813,UK10K_UKSCZ5072927,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
1,4488653,EGAN00001017478,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017478,Homo sapiens,,,1092799,UK10K_UKSCZ5072920,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
1,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
2,4488736,EGAN00001017487,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017487,Homo sapiens,,,1092817,UK10K_UKSCZ5072929,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
2,4488724,EGAN00001017488,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017488,Homo sapiens,,,1092819,UK10K_UKSCZ5072930,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
2,4488712,EGAN00001017489,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017489,Homo sapiens,,,1092821,UK10K_UKSCZ5072931,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
2,4488700,EGAN00001017490,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017490,Homo sapiens,,,1092823,UK10K_UKSCZ5072932,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
2,4488688,EGAN00001017491,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017491,Homo sapiens,,,1092825,UK10K_UKSCZ5072933,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
2,4488676,EGAN00001017486,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017486,Homo sapiens,,,1092815,UK10K_UKSCZ5072928,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
2,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
3,4488940,EGAN00001017496,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017496,Homo sapiens,,,1092835,UK10K_UKSCZ5072938,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
3,4488928,EGAN00001017497,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017497,Homo sapiens,,,1092837,UK10K_UKSCZ5072939,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
3,4488916,EGAN00001017498,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017498,Homo sapiens,,,1092839,UK10K_UKSCZ5072940,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
3,4488904,EGAN00001017499,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017499,Homo sapiens,,,1092841,UK10K_UKSCZ5072941,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
3,4488892,EGAN00001017492,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017492,Homo sapiens,,,1092827,UK10K_UKSCZ5072934,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
3,4488880,EGAN00001017493,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017493,Homo sapiens,,,1092829,UK10K_UKSCZ5072935,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
3,4488868,EGAN00001017494,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017494,Homo sapiens,,,1092831,UK10K_UKSCZ5072936,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
3,4488857,EGAN00001017495,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017495,Homo sapiens,,,1092833,UK10K_UKSCZ5072937,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
3,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
4,4488939,EGAN00001017504,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017504,Homo sapiens,,,1092851,UK10K_UKSCZ5072946,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
4,4488927,EGAN00001017505,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017505,Homo sapiens,,,1092853,UK10K_UKSCZ5072947,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
4,4488915,EGAN00001017506,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017506,Homo sapiens,,,1092855,UK10K_UKSCZ5072948,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
4,4488903,EGAN00001017507,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017507,Homo sapiens,,,1092857,UK10K_UKSCZ5072949,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
4,4488891,EGAN00001017500,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017500,Homo sapiens,,,1092843,UK10K_UKSCZ5072942,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
4,4488879,EGAN00001017501,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017501,Homo sapiens,,,1092845,UK10K_UKSCZ5072943,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
4,4488867,EGAN00001017502,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017502,Homo sapiens,,,1092847,UK10K_UKSCZ5072944,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
4,4488856,EGAN00001017503,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017503,Homo sapiens,,,1092849,UK10K_UKSCZ5072945,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
4,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
5,4488938,EGAN00001017512,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017512,Homo sapiens,,,1092867,UK10K_UKSCZ5072954,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
5,4488926,EGAN00001017513,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017513,Homo sapiens,,,1092869,UK10K_UKSCZ5072955,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
5,4488914,EGAN00001083713,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083713,Homo sapiens,,,1318722,UK10K_UKSCZ5260646,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
5,4488902,EGAN00001083715,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083715,Homo sapiens,,,1318724,UK10K_UKSCZ5260647,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
5,4488890,EGAN00001017508,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017508,Homo sapiens,,,1092859,UK10K_UKSCZ5072950,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
5,4488878,EGAN00001017509,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017509,Homo sapiens,,,1092861,UK10K_UKSCZ5072951,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
5,4488866,EGAN00001017510,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017510,Homo sapiens,,,1092863,UK10K_UKSCZ5072952,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
5,4488855,EGAN00001017511,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001017511,Homo sapiens,,,1092865,UK10K_UKSCZ5072953,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
5,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
6,4488937,EGAN00001083723,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083723,Homo sapiens,,,1318732,UK10K_UKSCZ5260651,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
6,4488925,EGAN00001083725,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083725,Homo sapiens,,,1318734,UK10K_UKSCZ5260652,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
6,4488913,EGAN00001083728,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083728,Homo sapiens,,,1318737,UK10K_UKSCZ5260653,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
6,4488901,EGAN00001083729,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083729,Homo sapiens,,,1318738,UK10K_UKSCZ5260654,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
6,4488877,EGAN00001083717,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083717,Homo sapiens,,,1318726,UK10K_UKSCZ5260648,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
6,4488865,EGAN00001083719,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083719,Homo sapiens,,,1318728,UK10K_UKSCZ5260649,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
6,4488854,EGAN00001083721,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083721,Homo sapiens,,,1318730,UK10K_UKSCZ5260650,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
6,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
7,4488936,EGAN00001083740,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ATCACG,1,Human all exon 50MB,Agilent Pulldown,ATCACG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083740,Homo sapiens,,,1318749,UK10K_UKSCZ5260659,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,1,
7,4488924,EGAN00001083742,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083742,Homo sapiens,,,1318751,UK10K_UKSCZ5260660,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
7,4488912,EGAN00001083744,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083744,Homo sapiens,,,1318753,UK10K_UKSCZ5260661,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
7,4488900,EGAN00001083747,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083747,Homo sapiens,,,1318756,UK10K_UKSCZ5260662,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
7,4488888,EGAN00001083748,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083748,Homo sapiens,,,1318757,UK10K_UKSCZ5260663,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
7,4488876,EGAN00001083734,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083734,Homo sapiens,,,1318743,UK10K_UKSCZ5260656,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
7,4488864,EGAN00001083736,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083736,Homo sapiens,,,1318745,UK10K_UKSCZ5260657,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
7,4488853,EGAN00001083738,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083738,Homo sapiens,,,1318747,UK10K_UKSCZ5260658,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
7,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
8,4488929,EGAN00001083761,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CGATGT,1,Human all exon 50MB,Agilent Pulldown,CGATGT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083761,Homo sapiens,,,1318770,UK10K_UKSCZ5260668,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,2,
8,4488917,EGAN00001083763,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TTAGGC,1,Human all exon 50MB,Agilent Pulldown,TTAGGC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083763,Homo sapiens,,,1318772,UK10K_UKSCZ5260669,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,3,
8,4488905,EGAN00001083764,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,TGACCA,1,Human all exon 50MB,Agilent Pulldown,TGACCA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083764,Homo sapiens,,,1318773,UK10K_UKSCZ5260670,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,4,
8,4488893,EGAN00001083765,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACAGTG,1,Human all exon 50MB,Agilent Pulldown,ACAGTG,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083765,Homo sapiens,,,1318774,UK10K_UKSCZ5260671,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,5,
8,4488881,EGAN00001083749,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,GCCAAT,1,Human all exon 50MB,Agilent Pulldown,GCCAAT,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083749,Homo sapiens,,,1318758,UK10K_UKSCZ5260664,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,6,
8,4488869,EGAN00001083750,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,CAGATC,1,Human all exon 50MB,Agilent Pulldown,CAGATC,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083750,Homo sapiens,,,1318759,UK10K_UKSCZ5260665,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,7,
8,4488858,EGAN00001083751,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\Homo_sapiens\1000Genomes\all\fasta\,ACTTGA,1,Human all exon 50MB,Agilent Pulldown,ACTTGA,cj5@sanger.ac.uk elg@sanger.ac.uk jws@sanger.ac.uk sm15@sanger.ac.uk,cj5@sanger.ac.uk elg@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,jws@sanger.ac.uk sm15@sanger.ac.uk,0,0,,,,,9606,S0782,645,UK10K,,,from:100 to:400,EGAN00001083751,Homo sapiens,,,1318760,UK10K_UKSCZ5260666,,,,168,EGAS00001000123,0,0,%09In the UK10K project we propose a series of complementary genetic approaches to find new low frequency%2Frare variants contributing to disease phenotypes. These will be based on obtaining the genome wide sequence of 4000 samples from the TwinsUK and ALSPAC cohorts (at 6x sequence coverage)%2C and the exome sequence (protein coding regions and related conserved sequence) of 6000 samples selected for extreme phenotypes. Our studies will focus primarily on cardiovascular-related quantitative traits%2C obesity and related metabolic traits%2C neurodevelopmental disorders and a limited number of extreme clinical phenotypes that will provide proof-of-concept for future familial trait sequencing. We will analyse directly quantitative traits in the cohorts and the selected traits in the extreme samples%2C and also use imputation down to 0.1%25 allele frequency to extend the analyses to further sample sets with genome wide genotype data. In each case we will investigate indels and larger structural variants as well as SNPs%2C and use statistical methods that combine rare variants in a locus or pathway as well as single-variant approaches. %0A%0AThe UK schizophrenia samples will be part of the neurodevelopmental disease group%2C and will undergo exome sequencing. ,1679,UK10K_NEURO_UKSCZ,Homo_sapiens (1000Genomes),UK10K exome sequence%3A UK schizophrenia samples,8,
8,4405872,phiX_for_spiked_buffers,C:\Illumina\MiSeq Reporter\Genomes\WTSI_references\PhiX\Illumina\all\fasta\,ACAACGCAAT,1,,,ACAACGCAAT,hps@sanger.ac.uk,,hps@sanger.ac.uk,hps@sanger.ac.uk,1,0,,,PhiX (10Jan12),,,,,,,,,,,,,1255141,phiX_for_spiked_buffers,,,,168,,0,0,None,198,Illumina Controls,,,168,
